We are monitoring the impact of COVID-19 on APAC Prostate Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 1539
Share on
Share on

Asia Pacific Prostate Cancer Market Research Report - Segmented By Diagnostic Techniques, Surgery, Radiation Therapy, Chemotherapy, By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Size, Share, Growth, Trends & Forecast to 2024

Pulished: August, 2019
ID: 1539
Pages: 145

APAC Prostate Cancer Market Size & Growth (2019 – 2024)

The size of the Prostate Cancer Market in the Asia Pacific was valued at USD 10.36 billion in 2019 and Expected to grow at a CAGR of 10.65%, to reach USD 17.18 billion by 2024 during the forecast period 2019-2024.

Prostate cancer is a common term used for the diseased situations in which abnormal cells grow and infect in an uncontrolled manner in the prostate. New product inventions, partnership agreements, collaborations, and acquisitions are some of the key strategies adopted by the players to get a large market share in the forecast period.

Advancement in technology, personalized medicine, cost-effective treatment procedures are a few other factors expected to provide a boost to the Asia-Pacific prostate cancer market. Rising incidence of prostate cancers and the availability of various treatment modalities are also fuelling market growth. However, limited commercially availability drugs and treatments for this cancer is the challenge restraining the growth of the prostate cancer market. Asia Pacific market is estimated to show a substantial growth rate due to the presence of high unmet needs in promising countries.

Asia Pacific Prostate Cancer Market segmented and sub-segmented into the following categories.

  • By Diagnostic Techniques: Digital Rectal Exam (DRE), Prostate-Specific Antigen Test (PSA).
  • By Surgery: Radial Prostatectomy, Orchidectomy, Trans Urethral Resection (TUR).
  • By Radiation Therapy: External Beam Radiation Therapy, Brachytherapy.
  • By Chemotherapy: Docetaxel, Etoposide, Vinblastine, Carboplatin, Vinorelbine.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC.

On the basis of region, China and India are estimated to grow at the highest rate due to the increasing cancer population.

Key Companies leading the Asia Pacific Prostate Cancer Market Profiled in the Report are Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech, etc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Techniques                           

                                5.1.1 Introduction           

                                5.1.2 Digital Rectal Exam (DRE)  

                                5.1.3 Prostate Specific Antigen Test (PSA)            

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Surgery                        

                                5.2.1 Introduction           

                                5.2.2 Radical Prostatectomy       

                                5.2.3 Orchidectomy        

                                5.2.4 Trans Urethral Resection (TUR)      

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Radiation Therapy                   

                                5.3.1 Introduction           

                                5.3.2 External Beam Radiation Therapy  

                                                5.3.2.1 3D Conformal Radiation Therapy

                                                5.3.2.2 Intensity Modulated Radiation Therapy

                                                5.3.2.3 Stereotactic Body Radiation Therapy

                                                5.3.2.4 Proton Beam Radiation Therapy

                                5.3.3 Brachytherapy      

                                                5.3.3.1 Permanent Brachytherapy

                                                5.3.3.2 Temporary Brachytherapy

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5 Market Attractiveness Analysis, By Application        

                                5.3.6 Market Share Analysis, By Application         

                5.4 Chemotherapy                         

                                5.4.1 Introduction           

                                5.4.2 Docetaxel

                                5.4.3 Etoposide

                                5.4.4 Vinblastine             

                                5.4.5 Carboplatin             

                                5.4.6 Vinorelbine            

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications          

                                5.4.8 Market Attractiveness Analysis, By Disease Indications        

                                5.4.9 Market Share Analysis, By Disease Indications         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Techniques

                                                6.1.3.3 By Surgery

                                                6.1.3.4 By Radiation Therapy

                                                6.1.3.5 By Chemotherapy

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Techniques

                                                6.1.4.3 By Surgery

                                                6.1.4.4 By Radiation Therapy

                                                6.1.4.5 By Chemotherapy

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Techniques

                                                6.1.5.3 By Surgery

                                                6.1.5.4 By Radiation Therapy

                                                6.1.5.5 By Chemotherapy

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Sanofi S.A                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline                      

                8.3 AstraZeneca               

                8.4 AbbVie                         

                8.5 Varian Medical Systems                        

                8.6 Elekta                           

                8.7 Theragenics               

                8.8 Pfizer                            

                8.9 Novartis                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Prostate Cancer Market By Diagnostic Techniques , From 2019-2024 ( USD Billion )
  2. Asia-Pacific Digital Rectal Exam (DRE) Market By Region, From 2019-2024 ( USD Billion )
  3. Asia-Pacific Prostate Specific Antigen Test (PSA) Market By Region, From 2019-2024 ( USD Billion )
  4. Asia-Pacific Prostate Cancer Market By Surgery, From 2019-2024 ( USD Billion )
  5. Asia-Pacific Radical Prostatectomy Market By Region, From 2019-2024 ( USD Billion )
  6. Asia-Pacific Orchidectomy Market By Region, From 2019-2024 ( USD Billion )
  7. Asia-Pacific Trans Urethral Resection (TUR) Market By Region, From 2019-2024 ( USD Billion )
  8. Asia-Pacific Prostate Cancer Market By Radiation Therapy , From 2019-2024 ( USD Billion )
  9. Asia-Pacific External Beam Radiation Therapy Market By Region, From 2019-2024 ( USD Billion )
  10. Asia-Pacific Brachytherapy Market By Region, From 2019-2024 ( USD Billion )
  11. Asia-Pacific Prostate Cancer Market By Chemotherapy , From 2019-2024 ( USD Billion )
  12. Asia-Pacific Docetaxel Market By Region, From 2019-2024 ( USD Billion )
  13. Asia-Pacific Etoposide Market By Region, From 2019-2024 ( USD Billion )
  14. Asia-Pacific Vinblastine Market By Region, From 2019-2024 ( USD Billion )
  15. Asia-Pacific Carboplatin Market By Region, From 2019-2024 ( USD Billion )
  16. Asia-Pacific Vinorelbine Market By Region, From 2019-2024 ( USD Billion )
  17. Japan Prostate Cancer Market By Diagnostic Techniques , From 2019-2024 ( USD Billion )
  18. Japan Prostate Cancer Market By Surgery, From 2019-2024 ( USD Billion )
  19. Japan Prostate Cancer Market By Radiation Therapy , From 2019-2024 ( USD Billion )
  20. Japan Prostate Cancer Market By Chemotherapy , From 2019-2024 ( USD Billion )
  21. China Prostate Cancer Market By Diagnostic Techniques , From 2019-2024 ( USD Billion )
  22. China Prostate Cancer Market By Surgery, From 2019-2024 ( USD Billion )
  23. China Prostate Cancer Market By Radiation Therapy , From 2019-2024 ( USD Billion )
  24. China Prostate Cancer Market By Chemotherapy , From 2019-2024 ( USD Billion )
  25. India Prostate Cancer Market By Diagnostic Techniques , From 2019-2024 ( USD Billion )
  26. India Prostate Cancer Market By Surgery, From 2019-2024 ( USD Billion )
  27. India Prostate Cancer Market By Radiation Therapy , From 2019-2024 ( USD Billion )
  28. India Prostate Cancer Market By Chemotherapy , From 2019-2024 ( USD Billion )
  29. Australia Prostate Cancer Market By Diagnostic Techniques , From 2019-2024 ( USD Billion )
  30. Australia Prostate Cancer Market By Surgery, From 2019-2024 ( USD Billion )
  31. Australia Prostate Cancer Market By Radiation Therapy , From 2019-2024 ( USD Billion )
  32. Australia Prostate Cancer Market By Chemotherapy , From 2019-2024 ( USD Billion )
  33. South Korea Prostate Cancer Market By Diagnostic Techniques , From 2019-2024 ( USD Billion )
  34. South Korea Prostate Cancer Market By Surgery, From 2019-2024 ( USD Billion )
  35. South Korea Prostate Cancer Market By Radiation Therapy , From 2019-2024 ( USD Billion )
  36. South Korea Prostate Cancer Market By Chemotherapy , From 2019-2024 ( USD Billion )
  37. Asia-Pacific Prostate Cancer Market By External Beam Radiation Therapy , From 2019-2024 ( USD Billion )
  38. Asia-Pacific 3D Conformal Radiation Therapy Market By Region, From 2019-2024 ( USD Billion )
  39. Asia-Pacific Intensity Modulated Radiation Therapy Market By Region, From 2019-2024 ( USD Billion )
  40. Asia-Pacific Stereotactic Body Radiation Therapy Market By Region, From 2019-2024 ( USD Billion )
  41. Asia-Pacific Proton Beam Radiation Therapy Market By Region, From 2019-2024 ( USD Billion )
  42. Japan Prostate Cancer Market By External Beam Radiation Therapy , From 2019-2024 ( USD Billion )
  43. China Prostate Cancer Market By External Beam Radiation Therapy , From 2019-2024 ( USD Billion )
  44. India Prostate Cancer Market By External Beam Radiation Therapy , From 2019-2024 ( USD Billion )
  45. Australia Prostate Cancer Market By External Beam Radiation Therapy , From 2019-2024 ( USD Billion )
  46. Asia-Pacific Prostate Cancer Market By Brachytherapy, From 2019-2024 ( USD Billion )
  47. Asia-Pacific Permanent Brachytherapy Market By Region, From 2019-2024 ( USD Billion )
  48. Asia-Pacific Temporary Brachytherapy Market By Region, From 2019-2024 ( USD Billion )
  49. Japan Prostate Cancer Market By Brachytherapy, From 2019-2024 ( USD Billion )
  50. China Prostate Cancer Market By Brachytherapy, From 2019-2024 ( USD Billion )
  51. India Prostate Cancer Market By Brachytherapy, From 2019-2024 ( USD Billion )
  52. Australia Prostate Cancer Market By Brachytherapy, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample